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ABSTRACT
Some of the most rapidly-evolving fields of study in the medical
and research communities presently are those which investigate our
genetic code, the elements and factors that control the expression of
our genetic code, as well as fields of study which analyze theories
about an organisms’ physiology and phenotype from the information
that both of the previous topics concomitantly provide. The work of the
Milavetz lab, among many others, is striving to fill the gaps in
knowledge about epigenetic regulation of biological processes – here
by using the well-suited model virus, Simian Virus 40.
It has for some time now been agreed upon that epigenetic
modifications of histone proteins not only exists, but play a crucial role
in biological processes related to the availability or condensation of
genetic material. Certain modifications have continuously been shown
to either silence or expose genes1,2. It has also been shown that these
modifications are not static but in a dynamic state3. However, the
details of how, when, and why changes in the epigenetic modifications
on the histone tails occurs is still being investigated.
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This project is intended to explore the effect of novel sequence
inserts into the SV40 genome related to the enhancer region, Sp1
binding site, and late promoter. Specific variants of SV40 were created
to contain either one or two copies of the enhancer region (T-129 and
T-143 respectively), two copies in succession of the Sp1 site (RH-43),
or a full late promoter region (T-165). Chromatin immunoprecipitation
(ChIP) and real-time quantitative polymerase chain reaction (q-PCR) of
the histone modifications H3K4me1/2/3, H3K9me1/2/3, H4K20me1
and RNAPII were analyzed.
We found that certain modifications were affected by each
sequence addition – some by a notable increase and some by a
notable decrease. While more data is needed to more wholly
characterize this phenomenon, these are some of the first results
indicating an association between the DNA sequence present and the
regulation of epigenetic histone modifications.
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CHAPTER I
INTRODUCTION
Deoxyribonucleic acid, or DNA, has sometimes been
referred to as the molecule of life. While many small molecules are
essential in the biological interworkings which support life, DNA is
considered especially important because it is the molecule that holds
all of the information necessary for the making of the proteins that
carry out the moment-to-moment interactions that define life, growth,
development, and even death. Since the discovery of DNA in 1869 by
Friedrich Miescher4, many great findings since then have led to a now
widely accepted understanding of the structure of DNA itself and the
process by which this genetic material is used to direct the formation
of functional molecules. The Central Dogma of Molecular Biology1,5
shows that the information encoded into strands of DNA are read by a
collection of cooperating proteins to produce ribonucleic acid (RNA) in
a process known as transcription. This RNA is ultimately read by
another conglomeration of molecules to produce proteins by the
process of translation (Figure 1).
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Figure 1. Central Dogma of Molecular Biology5.
Composition of DNA to form the Genome
DNA is composed of two long chains of nucleotides. The
nucleotides of one chain, or strand, of DNA are held together by
covalent bonds of the sugar-phosphate backbone to which the
nucleotides are attached. There are four types of nucleotides which
link, in a complementary and antiparallel fashion, to nucleotides of the
second DNA strand by hydrogen bonds. Figure 2 portrays how the
building blocks of DNA come together. The connections of the two
strands of DNA form a double-helical structure. This particular
2

Figure 2. The building blocks and structure of DNA1. Copyright 2008
from Molecular Biology of the Cell, Fifth Edition by Alberts et
al. Reproduced by permission of Garland Science/Taylor & Francis
LLC.
3

structure has characteristics that make it naturally advantageous for
both protecting the integrity of the nucleotide sequence from damage
while also presenting available binding sites for molecules essential to
biological processes such as transcription or replication6.
The entirety of the DNA sequence and thus all of the genetic
material is collectively referred to as an organisms’ genome. This
includes both protein-coding and non-coding sequences of DNA. The
segments of the sequence of DNA which code for functional proteins
are called genes. Although the human genome is approximated to
contain between 20,000 and 25,000 genes, they make up a
surprisingly small percentage of the total sequence – about 20% while the actual sequences that code directly for proteins is only
around 2-3%1,6.
The enormity of the amount of genetic material present in a
cell’s nucleus drives its need for orderly compaction. In humans, our
genetic material is divided into a set of 23 chromosomes. Figure 3
illustrates how genes are arranged within a particular chromosome.
The figure also demonstrates how small a percentage of the genetic
sequence is genes, and even smaller percentage is sequences that
directly code for proteins. How then does a cell organize 3200 km of
double-stranded DNA1 into a chromosome that is less than 10 µm? The
answer is the nucleosome.
4

Figure 3. The arrangement of genes within a human chromosome1.

Structure and Function of Nucleosomes
There are a variety of proteins that assist in the compaction of
DNA into its higher order structures which are either histones or
nonhistone chromosomal proteins. The term chromatin is used to
describe the entire assembly of both the DNA and these two classes of
proteins. DNA interacts with an arrangement of histone proteins to
form the first level of compaction, the nucleosome (Figure 4).

5

Figure 4. The structure of histones in the nucleosome1. Copyright 2008
from Molecular Biology of the Cell, Fifth Edition by Alberts et
al. Reproduced by permission of Garland Science/Taylor & Francis
LLC.
6

The characteristics of the different types of histone proteins in the
nucleosome show how they interact with one another, how they
condense DNA, and as we will see later the role they play in
determining gene expression.
Eight subunits of 4 types of histones – two from each category of
histone H2A, H2B, H3, and H4 – converge to form the disc-shaped
protein core of the nucleosome. One-hundred and forty-seven base
pairs of nucleotides wrap around this histone core almost twice and is
held there by numerous, reversible interactions between the
phosphodiester backbone of the DNA and the amino acid backbone of
the histones. Also, the high number of basic side chains like lysine and
arginine within the histones readily interact with the negatively
charged DNA1. A fifth type of histone, H1, is a linker histone which
binds to both the DNA as it comes off the nucleosome and the histone
core itself, assisting in the directionality of the DNA to bind with the
next core of histone proteins. Nucleosomes interdigitate further to
compact DNA into the 30 nm chromatin fibers of chromosomes.
As mentioned previously, the interactions between DNA and
histone proteins is reversible and in fact highly dynamic1,7. The cell has
just as much need for the DNA to be uncondensed and exposed when
replicating the genetic material or transcribing genes for protein
production as it does for compaction to protect the integrity of the
7

genetic sequence and repress gene expression. Maintenance and
control of the balance of appropriate response to the needs of the cell
occurs mostly by means of epigenetic regulation1,6,7.
Epigenetic Modifications Regulate Processing of Genetic Material
Epigenetics is a relatively new perception in the history of
biological concepts, however the inquiries it lends an understanding to
have long perplexed scientists. With the extraordinary amount of
genetic information and the remarkable expanses of similarity between
and even among species, how is it that life takes on such varied form
and function?
The notion of epigenetics began forming over a century ago8
with the idea that factors outside the genetic sequence alone could
have an impact on gene expression. The word epigenetics itself relates
to its mechanism in that the Greek prefix ‘epi’ means ‘upon’ or ‘over’9,
here relating to its function upon or over the genetic sequence versus
within1,8. It is now the understanding of the scientific community that
epigenetic modifications play a crucial role in most biological processes
by regulating gene expression8,10.
The two known types of epigenetic modifications occur on the
DNA itself – namely DNA methylation of cytosine residues – and on the
N-terminal tails of the histone proteins of the nucleosome where a
8

multitude of modifications can occur at a variety of sites (Figure 5). A
2007 review in Cell classified eight types of histone modifications and
characterized their biological effect11.

Figure 5. Histone tails and their epigenetic modifications1. Copyright
2008 from Molecular Biology of the Cell, Fifth Edition by Alberts et
al. Reproduced by permission of Garland Science/Taylor & Francis
LLC.
9

Acetylation, methylation, phosphorylation, ubiquitlyation, sumoylation,
ADP ribosylation, deamination, and proline isomerization have been
identified on specific residues. Table 1 list these modifications along
with the particular residue it modifies and the current understanding of
the biological process to which the modification relates.
Simian Virus 40
Simian virus 40, short-handed to SV40, was discovered in 1960.
Its native environment is in certain primate species where it typically
does not cause physiological issues except in animals with immune
system deficiencies13. It became a subject of interest in the following
years as it was found in the injected form of the polio vaccine which
the Centers for Disease Control estimates that as many as 98 million
Americans received between the years of 1955 and 196314. While
SV40 has not been proven to cause the formation of lesions or tumors,
SV40 has been identified in certain types of human cancers in recent
years15,16. Because of this association, an increase in research about
the characteristics and life cycle of SV40 has ensued, resulting in a
plethora of novel, useful information regarding not only tumorigenesis
but biological phenomena like DNA replication and transcription as
well13,15,17,18.
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Table 1. Epigenetic modifications of histones and their biological
effect12.

11

SV40 is categorized as a polyomavirus – small, contains DNA,
and has the potential to cause tumors. Figure 6 diagrams the SV40
genome along with the coded proteins that will be subsequently
discussed. With no viral envelope, the capsid containing the 5243-base
pair circular minichromosome enters the host cell via caveolin vesicle
formation after the virion glycoprotein VP1 binds to MHC class 1
receptors on the surface of the cell. Once inside the nucleus, RNA
polymerase II (RNAPII) initiates early gene expression and the
production of three tumor antigens: the important and multifunctional
large T antigen (LT), small T antigen (ST), and the less understood
17K T antigen.

Figure 6. Simian Virus 40
genome19,20.
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Large T antigen has three distinctive regions to carry out its
numerous functions. LT has been shown to inactivate cellular proteins,
like p53, thereby preventing apoptosis or cell cycle arrest; bind to and
recruit RNAPII and certain transcription factors essential for
perpetuating transcription of the viral DNA to the origin of replication;
as well as suppressing further early transcription and acting as a
helicase in assisting directionality of RNAPII in the transcription of late
genes21,22. The structure of LT is shown in Figure 7.

Figure 7. Large T antigen of Simian Virus 4019.
13

Late transcription gives rise to the structural viral capsid proteins
VP1, VP2, and VP3. All protein products of the SV40 genome return to
the nucleus and come together to form new virions. VP1 represents a
majority of the proteins making up the icosahedral-shaped SV40
capsid and, as mentioned previously, is considered the dominant link
between the virion and the new host cell membrane.
Because of its similarity to eukaryotic regulation of gene
expression and the fact that it relies completely on the host cell’s
machinery, SV40 is a well-suited model for studying DNA replication,
gene expression, and oncogenic transformation13,15,17,18,20 – and in the
case of our lab, the epigenetic characteristics of these biological
phenomena as well. Recent findings of this lab are continuing to
elucidate connections between epigenetic markers, like acetylation and
methylation, on specific lysine residues present within the tails of
histones like H3 and H4 in the viral nucleosome, and their subsequent
correlation with certain biological processes. For example,
hyperacetylated histones H3 and H4 have been shown to be associated
with p300 – a histone acetyl transferase – in the transcriptional
complex23. It has long been accepted that p300 works directly with
RNA polymerase II (RNAPII) in transcribing genetic material1,23, which
therefore links the hyperacetylation of H3 and H4 with the biological
process of transcription. The mono- and tri-methylation states of
14

histone H4 lysine 20 (H4K20me1 and H4K20me3, respectively) have
been shown to be present at separate time points during the SV40
infection18,24. Observed early in infection, H4K20me3 is thought to be
associated with the uncoating of the virus. H4K20me1 is conversely
found later on in the infection, both in replicating SV40 chromosomes
(also referred to as minichromosomes) as well as the virions
themselves suggesting a connection to encapsidation18. Most recently,
we have published data that supports the existence of transgenerational epigenetic regulation by SV4025. Along with this idea, we
detected multiple distinct sets of histone modifications that occur
together – which we termed an epigenome. Our lab has identified five
epigenomes in SV40 minichromosomes25 that will be explored as to
their relation to certain biological processes as well.
The focus of the research project for my thesis is centered on
the question of whether the epigenetic patterns we have noted to be
present within the SV40 virus are a sequence-dependent phenomenon
or a result of the initiation of a certain biological process like active
transcription.

15

CHAPTER II
METHODS
Cell Culture
The cells used for infections to produce the viral chromatin used
in the experiments were African green monkey kidney BSC-1 cells
obtained from American Type Culture Collection, Rockville MD, and
held at 37° C in a Napco Model 6200 CO2 incubator. The media used to
support the growth of the cells was minimum essential media (MEM)
containing Earle’s salts and L-glutamine in a 500 ml bottle purchased
from GIBCO, Invitrogen, supplemented with 5 mg/ml gentamicin
reagent solution antibiotics and 50 ml fetal calf serum (FCS) containing
growth factors, both also from GIBCO. The BSC-1 cells were
maintained in Corning tissue culture flasks, Fisher Scientific Company,
either 25 cm3 or 75 cm3 in size with approximately 10 ml or 20 ml FCS
and antibody-supplemented MEM, respectively. Twenty-five cm3 flasks
were generally used for HIRT preparations to check for efficiency of
infections whereas 75 cm3 flasks were typically used for chromatin
preparations – methodology presented in the following sections.
Growing cells were subcultured in the sterile environment of a Nuaire
16

laminar air flow hood Model NU 425-400. The refrigerated,
supplemented MEM and frozen bottle of trypsin-EDTA .05%
dissociation reagent, also from GIBCO, were warmed to room
temperature in a Stovall gyrating hybridization water bath. Then, the
flask of cells was checked by an Olympus light microscope to ensure a
confluent monolayer of cells present. The flasks were placed in the
hood where all remaining manipulations were conducted to ensure
sterility. The caps of the flasks were wiped with an Fisherbrand sterile
alcohol prep pad. The bottles and caps of the supplemented MEM and
trypsin-EDTA were also wiped with an alcohol prep pad. New 25 cm3 or
75 cm3 flasks for cell expansion were prepared with the addition of
approximately 10 ml or 20 ml of fresh media, respectively. The media
of the flask containing the confluent monolayer of cells was poured out
into a waste flask. Using Fisherbrand 5 ml glass pipettes and rubber
manual pipetter, 3 ml of trypsin-EDTA was added to the flask
containing the cells to be removed. The trypsin wash was rotated over
the cell layer manually for about 10 seconds to deactivate protease
inhibitors within the MEM and then discarded into the waste flask.
Using a new 5 ml pipette, 5 ml trypsin was added to the flask
containing the cells to be removed and this time laid flat within the
hood for approximately 1-2 minutes, allowing the trypsin to cover the
cells for that time. The flask was then checked in the microscope to

17

approximate the level of detachment of the cells before a few gentle,
manual taps were applied to the side of the flask to dislodge the cells
completely. A new 5 ml pipette was used to remove 3 ml of the trypsin
containing the now-detached cells and .5 ml was dispersed into each
of six 25 cm3 flasks or 1 ml into each of three 75 cm3 flasks, all of
which contain the appropriate amount of fresh media. Directly after
the trypsin containing detached cells was dispersed to the new flasks,
fresh MEM was added to the parent flask which still contains 2 ml
trypsin and detached cells. Caps on all flasks were secured and then
laid flat before returning to the CO2 incubator at 37° C. BS-C-1 cells
expanded to confluent monolayers in 2-3 days on average, at which
time they became ready for further subculturing or infection.
Preparation of Stock Viral Material
The wild-type 776 SV40 virus was a gift from Dr. Daniel
Nathans. The parent variant in the experiment (T-129) was created by
Dr. Barry Milavetz from a mutant of the 776 virus26, which was gift
from Dr. Thomas Shenk. T-129 had a deletion of the enhancer region
from nucleotide (nt) 128-200 and a deletion of the large T antigen
region from nt 4739-4882. It also contained an inserted reporter
segment with a polylinker at nt 2666 which contained sites recognized
by restriction endonucleases MluI, ApaLI, PmlI, NciI, and BglI. The
experimental constructs RH-43, T-143, and T-165 were prepared
18

previously in the Milavetz lab from the T-129 parent26,27. The variant
RH-43 contained an addition of multiple Sp1 sites, the variant T-143
included a second enhancer region, and the variant T-165 contained a
full late promoter region (figures in results section). Stock of the
different strains of virus were accumulated after 1 µl of the selected
variant was placed into a flask containing a mono layer of the BSC-1
cells and the supplemented media, and incubated until the virus had
infected most cells and released additional virions into the media
(approximately 10-14 days). The entire contents of the infected flask
were collected in a Corning 50 ml flat cap tube until being aliquoted for
subsequent infections.
Infection of BSC-1 Cells
Flasks containing confluent monolayers of cells ready for infection
were moved from the sterile CO2 incubator to the virus incubator, a
Napco Model 5100 CO2 incubator. A 500 ml bottle of GIBCO minimum
essential media, unsupplemented and dedicated for use with viral
infections, was also placed in the virus incubator to warm. Stock virus
that has been consolidated and aliquoted into 1.5 ml Eppendorf tubes
via the protocol in the section above was thawed per amount needed.
Typically .5 ml virus was used with 4.5 ml of media from the 25 cm3
flasks and 1 ml virus with 9 ml of media from the 75 cm3 flasks. Once
ready for infection, the flasks were moved to the virus-dedicated
19

NuAire NU-425-400 isolation hood. The proper amount of media was
poured off into a Corning 15 ml disposable flat-cap centrifuge tube
(4.5 ml or 9 ml). The remaining media in the flask was poured into
waste jars within the virus hood and the proper amount of media for
the infection returned to the flask from the 15 ml centrifuge tube. The
corresponding amount of virus was then placed into the proper flask
with a virus-dedicated Gilson pipette man and TipOne pipette tips.
Used tips were discarded in waste receptacle within virus hood.
Immediately following the addition of the virus, the flasks were
capped, laid flat, and rotated slightly to allow the virus to disperse
evenly throughout the media and onto the cell layer. The flasks were
incubated at 37° C for 30 minutes with the virus-media solution. At
the end of 30 minutes, the virus-media solution was discarded from
the flasks into the waste jars. The flasks were then washed twice with
approximately 5 ml or 10 ml (for 25 cm3 flasks or 75 cm3 flasks,
respectively) of the warmed, unsupplemented, virus-dedicated media
by rotating the flasks in all directions to remove any remaining
unbound virus from the inner surface of the flasks. The washes were
discarded into the waste jars and any excess was pipetted out and also
discarded. Next, 5 ml or 10 ml (for 25 cm3 flasks or 75 cm3 flasks,
respectively) of the warmed, unsupplemented, virus-dedicated media
was added to each flask. The flasks were then capped and placed back
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into the 37° C virus incubator for 30 minutes or 48 hours, depending
on the time-point of viral material needed.
HIRT
The HIRT method28 was used to determine whole-cell chromatin levels.
First, the desired 25 cm3 flasks that had been infected with virus 30
minutes or 48 hours previously were removed from the virus incubator
and placed in the virus hood. The media was discarded into the waste
jars. Dubecco’s Phosphate Buffered Saine (PBS) was used for two
washes of the flasks using approximately 5 ml of PBS each time and
rotating the flasks all directions to wash the entire inner surface of the
flasks. The washes were discarded into the waste jars and any excess
was pipetted out and also discarded. Once the washes have been
completed and all PBS removed, 300 µl lysing solution was added to
the flask (description of lysing solution can be found in Appendix B).
The flask was then held flat and rotated so that the lysing solution
covered the cell layer. The flask was continually rotated as the lysing
solution thickened, at which point it was pipetted into a 1.5 ml
Ependorf tube with a 101-1000 µl TipOne pipette tip and 10-1000 µl
Gilson pipette man. Two-hundred microliters of PBS was used to rinse
the sides of the flask, then pipetted off and added to the 1.5 ml
Eppendorf tube. Next, 160 µl Sodium chloride was squirted into the
1.5 ml Eppendorf tube being careful not to touch the pipette tip to the
21

sample. The sample was incubated overnight at 4°C, then spun at
12000 x g for 30 minutes at 4°C in a Eppendorf Centrifuge, model
5415C. The spin down formed a pellet of material at the bottom of the
1.5 ml Ependorf tube which was either pulled out of the tube with a
sterile wooden stick or the supernatant was carefully pipetted without
disturbing the pellet and placed into another 1.5 ml Ependorf tube. The
pellet was discarded. Samples were frozen at -20° C until ready for
glassmilk preparation and quantitative real-time polymerase chain
reaction (q-PCR), the protocols of which are in sections below.
Nuclei Isolation
The following procedure was used to isolate cellular nuclei for later
extraction of viral chromatin material. In preparation, a set of one 15
ml Corning flat-cap centrifuge tube and one 1.5 ml Ependorf tube per
flask being harvested was filled as follows. Fourteen milliliters of nuclei
preparation buffer (see Appendix B) was added to the 15 ml tube as
well as 15 µl PMSF (Sigma), mixed gently, then 1 ml of the buffer plus
PMSF was removed from the 15 ml tube and placed in the 1.5
Ependorf tube. Both tubes were held at 4° C until ready for use in
harvesting the cells. First, the desired 75 cm3 flasks that had been
infected with virus 30 minutes or 48 hours previously were removed
from the virus incubator and placed in the virus hood. The media was
discarded into the waste jars. Dubecco’s Phosphate Buffered Saine
22

(PBS) was used for two washes of the flasks using approximately 10
ml of PBS each time and rotating the flasks all directions to wash the
entire inner surface of the flasks. The washes were discarded into the
waste jars and any excess was pipetted out and also discarded. Once
the washes were completed and all PBS has been removed, 1 ml of the
buffer plus PMSF was taken from the 15 ml tube and added to the
flask. The solution was rotated over the cell surface of the flask until
completely covered with the liquid. A Fisherbrand disposable cell
scraper was then used to gently remove the cells from the surface of
the flask. Next, 1 ml 0.05% Triton X-100 (see Appendix B) was
pipetted to wash the dislodged cells to the bottom of the flask where
they were pipetted out and gently placed on top of the remaining 13
ml of buffer plus PMSF in the 15 ml tube. Once all material from the
flask was added to the 15 ml tube, it was centrifuged at 2500 rpm for
10 minutes at 4° C in a Beckman J6-M1 centrifuge. The spin down
formed a pellet of material at the bottom of the 15 ml tube. The
supernatant was discarded and 100 µl of buffer plus PMSF from the
1.5 ml Eppendorf tube was used to resuspend the pellet and transfer it
gently to the top of the remaining buffer plus PMSF in the 1.5 ml
Ependorf tube. This tube was centrifuged at 3000 x g for 10 minutes at
4° C. The spin down again formed a pellet at the bottom of the 1.5 ml
Eppendorf tube. The supernatant was removed without disturbing the
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pellet. Finally, the pellet was frozen at -20° C overnight before
performing extraction and gradient steps.
Nuclear Extraction
Nuclear extraction was performed to open up the nuclear envelope and
separate chromatin from other nuclear material. The desired nuclear
pellet was thawed then neutralized by resuspending with 75 µl
chromosome extraction buffer (see Appendix B). The solution was
vortexed (Lab-line Instruments, Inc.) for about 5 seconds and spun
down at 12000 x g for 30 seconds at room temperature. The
supernatant was pipetted off and discarded. Four-hundred microliters
of chromosome extraction buffer was used to again resuspend the
pellet. The Eppendorf tube was vortexed before holding at 4° C for 1
hour. After this extraction period, the tube was centrifuged at 12000 x
g for 10 minutes at 4° C. This spin down formed a pellet of material
that was discarded once the supernatant was taken off and either
transferred to a new, sterile 1.5 ml Eppendorf tube and frozen at -20°
C until further use or immediately run on a gradient (see next section).
Chromatin Gradient
Glycerol gradients were used to purify DNA for use in chromatin
immunoprecipitation (ChIP) protocols. The glycerol gradient was set up
in a 1.5 ml Eppendorf microcentrifuge tube. Two-hundred microliters
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of 50% glycerol (see Appendix B)were placed at the bottom of the
tube. Next, 1 ml of 10% glycerol (see Appendix B) was gently added
on top of the 50% glycerol base. The 400 µl of nuclear extraction
product from the previous step was added gently on top of the 10%
glycerol layer then centrifuged at 50,000 rpm for 35 minutes at 4° C in
a TLA 100.3 rotor within a Beckman TLA 100 ultracentrifuge. Upon
completion of the spin, 400 µl was carefully removed by pipette from
the top-down and discarded. The next 600 µl from the top of the
current level down was carefully removed and saved in a new, sterile
and appropriately labeled 1.5 ml Eppendorf tube. The content of this
sample was concentrated by glassmilk protocol and PCR-checked (see
steps below) before use in ChIP assays.
Chromatin Immunoprecipitation (ChIP)
Chromatin immunoprecipitation assays use antibodies to pull down
selected targets. The antibodies used in the experiments for this
particular study were from Millipore, Active Motif, abcam, Upstate, and
Santa Cruz Biotechnology. For our experiments, 7.8 µl of the selected
antibody were added to an Eppendorf Protein LoBind tube along with
170 µl protein agarose A and 750 µl ChIP dilution buffer from the
Millipore ChIP kit. This solution was rotated continuously at 4° C for
approximately 4 hours in a Labnet mini labroller. The tube was then
centrifuged at 2000 rpm in the Eppendorf Centrifuge model 5415C at
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room temperature for 1 minute to encourage the agarose to collect at
the base of the tube. The supernatant was removed and discarded.
Nine-hundred microliters of fresh ChIP dilution buffer from the exact
same ChIP kit was again added to the tube containing the agarose
along with 125 µl of the desired chromosomes that have previously
been run on a gradient. This solution was rotated continuously at 4° C
for approximately 12 hours. The tube was then centrifuged again at
2000 rpm at room temperature for 1 minute to encourage the agarose
to collect at the base of the tube. The supernatant was removed and
discarded. A series of 5 different washes of the agarose from materials
within the Millipore ChIP kit was performed in the following order: Low
Salt, High Salt, Lithium chloride (LiCl), Tris-EDTA (TE) buffer, and TrisEDTA (TE) buffer again. For each wash, 750 µl of the specified solution
was added to the tube containing the agarose, rotated continuously at
4° C for 10 minutes, centrifuged at 2000 rpm at room temperature for
1 minute to collect the agarose to the bottom of the tube, then the
supernatant carefully removed and discarded. After the fifth and final
wash and centrifugation, the supernatant was carefully taken off the
agarose and discarded as usual. One-hundred and twenty-five
microliters of fresh TE buffer was used to resuspend the agarose and
transfer it to a clean, sterile 1.5 ml Eppendorf tube. Two sequential 15
minute incubations at room temperature were conducted with 110 µl
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SDS lysing buffer each time. At the end of 15 minutes, the agarose
had again settled and the supernatant was carefully collected and
saved in a new, sterile and appropriately labeled 1.5 ml Eppendorf
tube. The collection of supernatant from the second SDS lysis buffer
incubation was added directly to the first in the new tube.
Concentrating with Glassmilk
Before quantitating with real-time PCR, all samples were concentrated
using GeneClean Spin Kit glassmilk kits from MP Biomedicals, LLC. All
glassmilk steps were conducted within the sterile environment of an
Air Clean 600 PCR workstation (ISC Bioexpress) using clean technique.
Fifty microliters of glassmilk was placed in a sterile 1.5 ml Eppendorf
tube, then 25 µl of the intended sample was gently mixed with the
glassmilk using the suction of the pipette man. The glassmilk plus
sample combination was allowed to sit for 10 minutes before being
spun down for 90 seconds at room temperature in a Southwest
Science microcentrifuge. The supernatant was carefully removed and
discarded. An ethanol wash of 125 µl was added to the tube where
pellet present was resuspended gently with the pipette man. The
solution was allowed to sit briefly before being spun down again at the
same conditions as previously done. The supernatant was again
carefully removed and discarded. The pellet was dried for 15 to 20
minutes, or until dry, in a Thermo Scientific Savant SPD Seppd Vac
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SPD 131DDA with RVT 4104 refrigerated vapor trap. Once completely
dried, 25 µl TE buffer was added to the pellet. Samples were stored
frozen at -20° C or PCR-ed immediately.
Quantitative real-time Polymerase Chain Reaction (qPCR)
All PCR preparation steps were conducted within the sterile
environment of an Air Clean 600 PCR workstation using clean
technique. The hood was first cleaned of possible contaminants using
DNA Zap two-part solution from Ambion. A ‘master mix’ solution was
prepared of 600 µl Bio-Rad SsoAdvanced SYBR green SuperMix; 585 µl
clean, nuclease-free water from Ambion; and 6 µl of both the forward
and reverse parts of a primer set. The primer set was designed by Les
Kallestad in the Milavetz lab using Primer-BLAST within the National
Center for Biotechnology Information’s website. The primers were of
the promoter region with the sequences 5`TTG CAA AAG CCT AGG
CCT CCA AA 3` and 5`TGA CCT ACG AAC CTT AAC GGA GGC 3`. The
‘master mix’ was thoroughly vortexed before using and prepared
immediately before being aliquoted and combined with a sample to be
PCR-ed. Twenty-nine microliters of ‘master mix’ was placed into a VWR
0.2 µl flat cap PCR tube. The glassmilk sample to be added was
appropriately, manually agitated to form an evenly resuspended
solution of the glassmilk within the TE buffer. Two microliters of this
glassmilk-TE buffer solution was then immediately pipetted out with a
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PCR-dedicated, sterile Gilson 0.1 – 2 µl pipette man and TipOne
pipette tips, and added to the ‘master mix’ in the PCR tube. Samples
were normally prepared in triplicate and quantitative real-time PCR
was carried out using a Bio-Rad CFX Connect Real-Time System and
the accompanying Bio-Rad CFX Manager 2.1 software. The cycle
pattern was set up to begin with a 15 minute “hot start” of 95° C, then
55 cycles of one minute at 95° C to one minute at 60° C followed by
one minute at 72° C. The program also performed a melt curve
analysis – heating from 65° C to 95° C in five second intervals – at the
end of the 55 cycles of amplification which we referred to for quality of
amplified sample.
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CHAPTER III
RESULTS
Construction of SV40 Variants
The parent construct in the experiment, T-129, is a variant of
the SV40 wild type virus which has a deletion of an intron from the
large T antigen coding region (nt 4739-4882) and a deletion of one of
the enhancers from the nucleosome free region near the origin of
replication (nt 128-200). The T-129 construct also contains an input
reporter region with a polylinker (nt 2666) that contains sites sensitive
to restriction endonucleases Mlu I, Apa LI, Pml I, Nci I, Bgl II26,27.
These sites allowed the insertion of the various sequences of interest
producing the variants used in the experiment. Figure 8 diagrams the
setup of the T-129 parent construct as well as three experimental
variants. RH-43 contains an additional two copies of the Sp1 binding
site (nt 40-59) between the Mlu I and Apa LI restriction sites. Variant
T-143 contains the second enhancer region (nt 103-178), again
between the Mlu I and Apa LI sites. The T-165 variant included the
whole late promoter (nt 255-424) and was also positioned between the
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same two restriction endonuclease sites as with the previously
described variants.
Quality Control of Virus, Infection, and Experimental Conditions
The parameters of the experiments conducted were controlled
for as much as possible by conducting quality control checks for the
infectivity of the virus variants, optimal infection conditions, as well as
ideal ChIP conditions. Newly produced virus was checked by HIRT
procedure along with q-PCR to ensure new batches of virus were
comparably infective of cells. The amount of virus used in infections,

Figure 8. SV40 parent variant, T-129, and experimental variants
RH-43, T-143, and T-16526,27.
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Figure 9. SV40 infection optimization.
the length of time the cells are first exposed to the virus, and the age
of the cells at the time of infection were compared. The data collected
used wild-type SV40 virus (776) and shows that the highest amount of
whole cell viral material for a 48 hour infection is initiated when the
cells are approximately 2.5 days post subculture (Figure 9, top). The
highest amount of viral chromatin obtained from a 48 hour infection
occurs when the infection is initiated 4.5 days post subculture or later
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(Figure 9, bottom). This information was considered for the infections
used to produce the selected viral chromatin for the ChIP experiments.
ChIP/q-PCR Reveal Changes in Ratios of Modifications Present
The ChIP experiments were carried out via protocols described in
the methods section previously. After the ChIP products were
subjected to q-PCR, statistics were used to calculate both the
percentage of modified chromatin bound by the ChIP and the ratio of
those percentages between the SV40 variants RH-43, T-143, and T165 and the parent virus T-129. Cycle thresholds produced by the
software of the q-PCR system indicate the number of cycles completed
when fluorescence of the incorporated SYBR green are first able to be
detected. These cycle thresholds (Ct) were used to calculate the
comparisons (Table 2).
To compute the percentage of the input chromatin bound by the
selected antibody, the Ct of the un-ChIPed input chromatin was
subtracted from the Ct of the related ChIP product to give a Ct
difference. Given that amplification by q-PCR reaction should yield
twice the amount of product from each cycle, one divided by 2 to the
power of the Ct difference revealed the percent of the whole input
chromatin pulled down by the antibody (%) and inferring the
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Avg
Stdev
n
Avg
Stdev
n
Avg
Stdev
n
Avg
Stdev
n

0.001
0.001

0.017
0.022

2

3

3

1.020
1.389

0.720
0.452
0.263
0.004

0.106
0.098

2

3

4

0.460
0.170

0.510
0.469

0.802
0.654

0.318
0.382

0.031
0.040

2.927
1.072

H3K4me2
%
Ratio
0.358
0.339

H3K4me1
%
Ratio
0.017
0.017

0.980
0

1.275
1.720

2.461
1.063

1

3

3

0.700 6.337
0 9.609

1.867 10.58
0.266 6.452

5

2

4

1.606
1.211

1.125
0.278

0.813
0.249

H3K9me1
%
Ratio
6.423
5.035

1.250 4.943
0.157 3.553

H3K4me3
%
Ratio
0.363
0.692

0.393
0.351

0.573
0.789

0.455
0.601

3

2

2

0.373
0.252

0.375
0.276

0.535
0.149

H3K9me2
%
Ratio
0.850
0.690

Table 2. Percent and Ratios of Histone Modifications in SV40 variants.

T-129

RH-43

T-143

T-165
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1.375 1.518
1.874 1.3818
4
0.995 1.440
1.365 1.513
2
0.397 0.263
0.556 0.225
3

H3K9me3
%
Ratio
0.435
0.488

2

3
0.155
0.120

0.380
0.044

n/a

0.026
0.036

0.030
0.051

H4K20me1
%
Ratio
0.074
0.122

0.010
0.009

0.004
0.005

0.002
0.003

2

2

2

0.890
0.156

1.500
0.354

1.000
0

RNAPII
%
Ratio
0.008
0.012

percentage of the input chromatin containing the particular histone
modification.
The ratio of the amount of a certain modification seen in the
ChIP products of the variants to that of the ChIP product of the T-129
parent was calculated by dividing the percent (%) of a variant by the
percent (%) of the T-129 parent within the same ChIP experiment.
Average values of these computations are shown in Table 2. Ratios of
close to 2 or higher indicate a prominent increase in the amount of the
modification present as a result of the sequence addition of the
variant. Ratios of down to 0.5 or less indicate a notable decrease in
the amount of modification present as a result of the input sequence of
the variant.
The average ratios of the variants for the selected histone
modifications from Table 2 was graphed to more readily display any
notable changes (Figure 10). RH-43, the variant containing an input
sequence of two Sp1 binding sites, saw a noteworthy increase in the
amount of H3K4me1 compared to the T-129 parent. Distinguishable
decreases in H3K9me2 and H4K20me1 modification were also
observed for the RH-43 variant (Figure 10, top panel). T-143, having a
reintroduced second enhancer region, showed a prominent increase in
H3K4me3 while also displaying notable decreases in H3K9me2 and
H4K20me1 (Figure 10, middle panel). T-165, the variant containing an
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Figure 10. Ratios of the selected modifications present in SV40
variants to the T-129 parent.
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addition of the late promoter sequence, resulted in decreases in
H3K9me1 and H3K9me2 as well (Figure 10, bottom panel). The green
line on the graphs is intended to assist in distinguishing notable
increases or decreases in the ratio of modifications present in the
variant versus the T-129 parent. The error bars represent one
standard deviation of the average ratio of the variant to T-129. In this
set of experiments, the antibody to RNAPII is intended as an internal
control as RNAPII is traditionally a good marker for active
transcription. As it relates to this experiment, the ratio of RNAPII does
not increase or decrease significantly for the RH-43 or T-165 variants
but perhaps a slight increase in T-143 (Figure 10, middle panel). This
may suggest that the additional enhancer sequence in the T-143
variant could be associated with an increase in active transcription.
However, more investigation is needed to confirm this observation.
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CHAPTER IV
DISCUSSION
From the results of the initial experiments conducted and shown
here, we can conclude that the presence of specific sequences is
associated with changes in the amounts of certain histone
modifications seen on SV40 minichromosomes. Additionally, it is
important to note that the sequences inserted into the respective
variants are known to be associated with gene activation (Table 1).
The Sp1 binding sites added to RH-43 bind Specificity Protein 1 – a
transcription factor known to be involved in gene expression in early
development1,29. The increase in the ratio of H3K4me1, a modification
associated with gene activation (Table 1); as well as the decreases in
H3K9me2 and H4K20me1, modifications associated with gene
repression (Table 1), both suggest that the addition of sequences
involved in transcription also affects the histone modifications related
to that biological process. Similarly, enhancer regions – like the one
added to variant T-143 – are segments of DNA that bind trans-acting
factors and enhance gene transcription30,31. Therefore the increase in
the ratio of H3K4me3, again a modification associated with gene
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activation, and the decreases in the ratios of H3K9me2 and H4K20me1
further support our hypothesis. The T-165 variant contained an
additional late promoter, which is also a sequence involved in initiating
the transcription of particular genes26. The decreased ratios of
H3K9me2 and H3K9me3 provide continued support for the notion that
sequences can drive epigenetic modification of histones.
An additional piece of information that can be deduced from the
data is one which is also recently being supported in other literature.
Since the discovery of the different modifications that can be present
on histones, it was assumed that methylation of any state would serve
essentially the same purpose1,32,33,34. Our data suggests this may not
be the case and that different methylation states can be associated
with the functioning of different sequences. The mono-methylated
form of H3K4 was affected by the addition of Sp1 binding sites in RH43, but the di- and tri-methylated states were unaffected (Figure 10,
top panel).With the T-143 variant and its addition of a second
enhancer region, the tri-methylated state of H3K4 saw an increase,
however the mono- and di-methylated states did not show change
(Figure 10, middle panel). Even though the Sp1 binding site and
enhancer regions of a DNA sequence have both been associated with
gene transcription and all three methylated stated of H3K4 are
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connected to gene activation (Table 1), the different methylated states
appear to be regulated separately.
Our lab plans to continue investigating this phenomenon to
better understand the maintenance and regulation of histone
modifications and their biological relevance by experimenting with
different sequence inputs to determine if other sequences have an
effect on the amount of a particular modification present. We could
also look into the outcome of the position of the input sequence within
the SV40 genome to establish if there is a positional effect. There are
also a multitude of antibodies to other histone modifications that can
be tested. The overall aim of this and future research of epigenetic
modifications is to better understand the mechanisms by which the cell
controls, and the environment affects, gene expression. This
information, we are already seeing, could ultimately have broad
implications in the fields which study human diseases and
development.
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APPENDICIES

Appendix A
Commonly Used Abbreviations
DNA

deoxyribonucleic acid

RNA

ribonucleic acid

RNAPII

ribonucleic acid polymerase II

H3K4

histone 3 lysine 4

H3K9

histone 3 lysine 9

H4K20

histone 4 lysine 20

me1

monomethyl

me2

dimethyl

me3

trimethyl

km

kilometers

nm

nanometers

μm

micrometers

SV40

Simian virus 40

LT

large T antigen

°C

degrees Celsius

cm3

cubic centimeters

L

liters

ml

milliliters
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µl

microliters

nt

nucleotide

Sp1

Specificity protein 1

PBS

Phosphate Buffered Saline

PMSF

phenylmethylsulfonyl fluoride

xg

gravity constant

ChIP

Chromatin immunoprecipitation

q-PCR

quantitative real-time polymerase chain
reaction

g

grams

M

molar

mM

millimolar
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Appendix B
Solutions and Buffers
Lysing solution (HIRT)

6.0 ml 10% SDS, 2.0 ml 0.1 M EDTA,
add Milli-Q water to 100 ml

10% SDS

100 g SDS, add Milli-Q water to 1.0 L

0.1 M EDTA (pH 8.0)

3.8 g EDTA, add water to 100 ml

Milli-Q water

Water purified by Milli-Q Water
Purification System (Millipore)

Sodium chloride (HIRT)

292.2 g NaCl, add Milli-Q water to 1 L

Nuclei Preparation
Buffer (pH 7.4)

50 ml glycerol (5%), 0.84 g HEPES (2
nM), 5 ml 0.1 M MgCl2 (0.2 mM), 5 ml
0.1 M PMSF* (0.5 mM), 5 ml 0.1 M DDT*
(0.5 mM), add Milli-Q water to 1 L;
autoclave sterilize
*add after autoclaving, filter sterilize

0.1 M MgCl2

2.03 g MgCl2 : 6 H20, add water to 100
ml

0.1 M PMSF

1.74 g PMSF, add ethanol to 100 ml

0.1 M DDT

0.77 g DDT, add water to 50 ml

0.05% Triton

50 ml Triton X-100, add water to 100 ml

Chromosome Extraction
Buffer (pH 7.5)

0.24 g HEPES (10 mM), 1 ml 0.1 M EDTA
(1 mM), 0.5 ml 0.1 M DDT (0.5 mM), 0.1
ml 0.1 M PMSF (0.1 mM), add Milli-Q
water to 100 ml, filter sterilize
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Chromatin Gradient
Solutions (pH 7.5)

1.19 g HEPES (10 mM), 0.186 g KCl (5
mM), 5 ml 0.1 M EDTA (1 mM), 1 ml 0.1
M MgCl2 (0.2 mM), 2.5 ml 0.1 M DDT
(0.5 mM), add 50 ml glycerol for 10%
glycerol solution or 250 ml glycerol for
50% glycerol solution, add water to 500
ml, autoclave sterilize

All glassware and solutions autoclaved in a Castle M/C 3500 Series
Sterilizer (Gentige-Castle). All solutions adjusted to the indicated pH
using either 6 M NaOH or 6 M HCl.
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